Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Mechoulam

Showing results (181-190 of 183) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 183 results.
JAMA Network Open|August 13, 2021
Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic: A Randomized Clinical TrialJosé Alexandre S Crippa, Antonio W Zuardi, Francisco S Guimarães, et al.
Frontiers in Pharmacology|October 20, 2022
Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemicJosé Diogo S Souza, Antonio W Zuardi, Francisco S Guimarães, et al.
Cannabis and Cannabinoid Research|October 7, 2021
Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical TrialJosé Alexandre S Crippa, Julia Cozar Pacheco, Antonio W Zuardi, et al.
Pageof 19

Showing results (181-190 of 183) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 183 results.
JAMA Network Open|August 13, 2021
Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic: A Randomized Clinical TrialJosé Alexandre S Crippa, Antonio W Zuardi, Francisco S Guimarães, et al.
Frontiers in Pharmacology|October 20, 2022
Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemicJosé Diogo S Souza, Antonio W Zuardi, Francisco S Guimarães, et al.
Cannabis and Cannabinoid Research|October 7, 2021
Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical TrialJosé Alexandre S Crippa, Julia Cozar Pacheco, Antonio W Zuardi, et al.
Pageof 19